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Background
Virus specific CD4+ T helper response is critical for main-
tenance of effective immunity against chronic viral infec-
tions. Vigorous HIV-specific T cell responses were found
associated with control of viremia in HIV infected individ-
uals. However, in most of the HIV infected individuals,
virus specific CD4+ T cell responses are very low or unde-
tectable. While the virus envelope is a critical target for the
immune responses, this antigen is poorly immunogenic,
especially for CD4+ T cells. One of the possible reasons is
the heavy glycosylation of the envelope glycoproteins. In
this study, we examined the effects of site-specific de-glyc-
osylation on the presentation of gp120 antigen to the
CD4+ T cells.
Materials and methods
Three potential N-linked glycosylation sites located in or
flanking the CD4+ T cell epitope clusters in the C4 region
of gp120 IIIB were disrupted by site-directed mutagenesis
(N to Q) to generate mutants with single or multiple N-
glycan deletions. Recombinant proteins were expressed in
CHO cells, purified by affinity chromatography and ana-
lyzed for reactivity with soluble CD4 and various anti-
gp120 mAbs in ELISA. The wild type and mutated pro-
teins were then tested in 3H-thymidine incorporation
assays for recognition by a mouse CD4+ T cell clone and
a human CD4+ T cell line with specific C4 epitopes.
Results
The reactivities of all of the mutated gp120 proteins to
sCD4 and anti-gp120 mAbs were comparable to the wild
type, suggesting that no major conformation changes
occurred after removal of the specific glycan(s). However,
the removal of one N-linked glycans at the C4 region
decreased recognition of CD4+ T cells tested, while the
deletion of the two other glycans had either slightly
enhancing or no effects. Studies are on-going to assess
what steps in antigen processing and presentation are
affected by these N-glycan removals. In addition, the
effects of these mutations on recognition of CD4 T cell
specific for epitopes in other regions (C1, C2 and V3) of
gp120 are being analyzed.
Conclusion
Removal of certain glycan(s) near a T cell epitope cluster
of gp120 did not alter its reactivity with CD4 and mAbs,
but could modulate the recognition of these epitopes by
CD4 T cells.
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